Annovis Bio, Inc. (ANVS)
1.92
+0.02
(+1.05%)
USD |
NYSE |
May 29, 16:00
1.97
+0.05
(+2.60%)
After-Hours: 20:00
Annovis Bio Total Assets (Quarterly) : 16.24M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 460.00M |
| Gain Therapeutics, Inc. | 18.74M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Anika Therapeutics, Inc. | 179.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.12M |
| Shareholders Equity (Quarterly) | 3.126M |
| Current Ratio | 1.27 |